When evaluating parameter uncertainty is not enough: the case of dasatinib and nilotinib for imatinib-resistant chronic myeloid leukemia.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Reed, SD

Published Date

  • December 2011

Published In

Volume / Issue

  • 14 / 8

Start / End Page

  • 1055 - 1056

PubMed ID

  • 22152174

Pubmed Central ID

  • 22152174

Electronic International Standard Serial Number (EISSN)

  • 1524-4733

International Standard Serial Number (ISSN)

  • 1098-3015

Digital Object Identifier (DOI)

  • 10.1016/j.jval.2011.10.001

Language

  • eng